PortfoliosLab logo

Infinity Pharmaceuticals, Inc. (INFI)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US45665G3039
CUSIP
45665G303

INFIPrice Chart


Chart placeholderClick Calculate to get results

INFIPerformance

The chart shows the growth of $10,000 invested in Infinity Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,180 for a total return of roughly -78.20%. All prices are adjusted for splits and dividends.


INFI (Infinity Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INFIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-36.44%-2.17%
1M-41.15%0.62%
6M-45.21%6.95%
1Y-46.44%22.39%
5Y-0.95%15.44%
10Y-16.81%13.73%

INFIMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

INFISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Infinity Pharmaceuticals, Inc. Sharpe ratio is -0.47. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


INFI (Infinity Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INFIDividends


Infinity Pharmaceuticals, Inc. doesn't pay dividends

INFIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


INFI (Infinity Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INFIWorst Drawdowns

The table below shows the maximum drawdowns of the Infinity Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Infinity Pharmaceuticals, Inc. is 98.63%, recorded on Mar 16, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.63%Apr 3, 20131751Mar 16, 2020
-42.3%Jul 22, 2011131Jan 27, 201237Mar 21, 2012168
-41.81%May 13, 201071Aug 23, 2010213Jun 27, 2011284
-34.25%Oct 8, 201222Nov 8, 201221Dec 10, 201243
-16.79%Jul 30, 20128Aug 8, 201214Aug 28, 201222
-12.88%May 11, 201217Jun 5, 20128Jun 15, 201225
-11.1%Jan 4, 20137Jan 14, 201324Feb 19, 201331
-9.3%Jan 5, 201064Apr 7, 20105Apr 14, 201069
-9.19%May 5, 20103May 7, 20102May 11, 20105
-9.05%Mar 18, 20136Mar 25, 20134Apr 1, 201310

INFIVolatility Chart

Current Infinity Pharmaceuticals, Inc. volatility is 114.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


INFI (Infinity Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Infinity Pharmaceuticals, Inc.


Loading data...

More Tools for Infinity Pharmaceuticals, Inc.